Citation

Jawaid A, Rademakers R, Kass JS, Kalkonde Y, Schulz PE. Neurodegener. Dis. 2009; 6(5-6): 219-220.

Affiliation

Department of Neurology, Baylor College of Medicine, Houston, Tex., USA.

Copyright

(Copyright © 2009, Karger Publishers)

DOI

10.1159/000258704

PMID

20145419

PMCID

PMC2837889

Abstract

Frontotemporal lobar degeneration with TAR-DNA-binding protein inclusions (FTLD-TDP) is the most common pathological subtype of frontotemporal dementia (FTD). Mutations leading to a loss of function in the progranulin gene (PGRN) are the most common known cause of FTLD-TDP. In agreement with the proposed loss of function disease mechanism, several groups have reported decreased plasma levels of PGRN in patients carrying PGRN mutations compared to individuals without PGRN mutations. We propose that traumatic brain injury (TBI), an environmental factor, may also increase the risk of FTD by altering PGRN metabolism. TBI may lead to an increase in the central nervous system levels of microglial elastases, which proteolyze PGRN into proinflammatory products called granulins causing a reduction in PGRN levels. Hence, inhibiting microglial activation may have an important implication for the prevention of FTD in patients with TBI.

Language: en